News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
371,019 Results
Type
Article (11250)
Company Profile (52)
Press Release (359717)
Section
Business (123571)
Career Advice (393)
Deals (21516)
Drug Delivery (30)
Drug Development (43329)
Employer Resources (33)
FDA (8555)
Job Trends (10464)
News (198163)
Policy (17041)
Tag
Academia (1658)
Africa (278)
Alliances (21002)
Alzheimer's disease (648)
Approvals (8536)
Arizona (72)
Artificial intelligence (40)
Asia (22693)
Australia (2927)
Bankruptcy (139)
Best Places to Work (9187)
Biotechnology (45)
Breast cancer (51)
C2C Services and Suppliers (34979)
California (1307)
Canada (547)
Cancer (391)
Career advice (322)
Cell therapy (79)
China (136)
Clinical research (35027)
Collaboration (107)
Colorado (59)
Connecticut (56)
COVID-19 (1136)
Cystic fibrosis (43)
Data (334)
Diabetes (54)
Diagnostics (4110)
Earnings (67833)
Europe (43461)
Events (71727)
Executive appointments (100)
FDA (8751)
Florida (204)
Funding (103)
Gene therapy (46)
Georgia (41)
GLP-1 (218)
Government (2490)
Healthcare (14924)
Hotbed/Location (271123)
Idaho (36)
Illinois (172)
Indiana (125)
Infectious disease (1146)
Inflammatory bowel disease (64)
Interviews (59)
IPO (12392)
Job creations (1404)
Job search strategy (291)
Kansas (56)
Layoffs (174)
Legal (3487)
Lung cancer (88)
Maine (43)
Manufacturing (51)
Maryland (352)
Massachusetts (1129)
Medical device (9404)
Medtech (9405)
Mergers & acquisitions (9134)
Metabolic disorders (121)
Michigan (89)
Minnesota (159)
Neuroscience (752)
New Hampshire (42)
New Jersey (455)
New York (411)
NextGen Class of 2024 (5211)
Non-profit (4193)
North Carolina (430)
Northern California (581)
Obesity (71)
Ohio (80)
Opinion (56)
Pennsylvania (379)
People (26281)
Phase I (10310)
Phase II (15379)
Phase III (12559)
Pipeline (121)
Postmarket research (1177)
Preclinical (3462)
Press Release (61)
Radiopharmaceuticals (142)
Rare diseases (78)
Real estate (2736)
Regulatory (11641)
Research institute (1475)
Resumes & cover letters (72)
South America (517)
Southern California (562)
Startups (1313)
Texas (176)
United States (6208)
Utah (43)
Vaccines (162)
Washington State (169)
Weight loss (46)
Date
Last 7 days (426)
Last 30 days (1491)
Last 365 days (23838)
2024 (17503)
2023 (26922)
2022 (30893)
2021 (34999)
2020 (37345)
2019 (37142)
2018 (27040)
2017 (19876)
2016 (19677)
2015 (23175)
2014 (12764)
2013 (9617)
2012 (10164)
2011 (10407)
2010 (9421)
371,019 Results for "30".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Singular Genomics Announces 1-for-30 Reverse Stock Split
Singular Genomics Systems, Inc. announced that on June 26, 2024, effective at 12:01 a.m. Eastern Time, it will effectuate a 1-for-30 reverse split of its common stock.
June 21, 2024
·
5 min read
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024
Scilex Holding Company provided certain preliminary unaudited financial results for the month ended June 30, 2024 and quarter ended June 30, 2024.
July 1, 2024
·
8 min read
Press Releases
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024
Avid Bioservices, Inc. today announced that it will report financial results for the quarter and fiscal year ended April 30, 2024, on July 2, 2024, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).
July 1, 2024
·
1 min read
Press Releases
Bionano Adjourns Special Meeting of Stockholders to October 30, 2024
October 4, 2024
·
5 min read
Business
Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30
Merck, known as MSD outside of the United States and Canada, will hold its second-quarter 2024 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Tuesday, July 30.
July 1, 2024
·
3 min read
Press Releases
FDA Roundup: August 30, 2024
September 2, 2024
·
3 min read
Press Releases
Humacyte Announces Pricing of $30.0 Million Registered Direct Offering
October 4, 2024
·
6 min read
Press Releases
Interim results for the six months ended June 30, 2024
September 27, 2024
·
58 min read
Press Releases
Savara to Host Analyst and Investor Webinar on September 30, 2024
September 23, 2024
·
1 min read
Business
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024
Pharma-Bio Serv, Inc. announced that revenues for the three and six months ended April 30, 2024 were approximately $2.4 and $4.8, million, respectively, a decrease of approximately $2.2 and $4.0 million when compared to the same periods last year.
June 14, 2024
·
2 min read
1 of 37,102
Next
